Pharmaceutical Calcimimetics
    1.
    发明申请
    Pharmaceutical Calcimimetics 审中-公开
    药物计算

    公开(公告)号:US20110092468A1

    公开(公告)日:2011-04-21

    申请号:US12975464

    申请日:2010-12-22

    CPC分类号: C07B59/001

    摘要: This invention relates to novel calcimimetic compounds, their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by binding to, and modulating the sensitivity of, calcium receptors on the parathyroid gland.

    摘要翻译: 本发明涉及新的拟钙化合物,其衍生物,药学上可接受的盐,溶剂合物和水合物。 本发明还提供了包含本发明化合物的组合物和这些组合物在治疗通过与甲状旁腺上的钙受体结合并调节其敏感性有益治疗的疾病和病症的方法中的用途。

    Pharmaceutical Calcimimetics
    2.
    发明申请
    Pharmaceutical Calcimimetics 审中-公开
    药物计算

    公开(公告)号:US20080261926A1

    公开(公告)日:2008-10-23

    申请号:US12060371

    申请日:2008-04-01

    CPC分类号: C07B59/001

    摘要: This invention relates to novel calcimimetic compounds, their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by binding to, and modulating the sensitivity of, calcium receptors on the parathyroid gland.

    摘要翻译: 本发明涉及新的拟钙化合物,其衍生物,药学上可接受的盐,溶剂合物和水合物。 本发明还提供了包含本发明化合物的组合物和这些组合物在治疗通过与甲状旁腺上的钙受体结合并调节其敏感性有益治疗的疾病和病症的方法中的用途。